Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor

Data Brief. 2019 Jan 9:22:903-908. doi: 10.1016/j.dib.2019.01.009. eCollection 2019 Feb.

Abstract

The data presented in this article are connected to our research article entitled "D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo" (Furlan et al., 2018). These data further extend our understanding of the inhibitory effects of D2A-Ala peptide. Dose-response curve using a wide range of concentrations of D2A-Ala shows that this peptide has no effects per se on proliferation of rat smooth muscle cells (RSMC). However, D2A-Ala dose-dependently inhibits epidermal growth factor (EGF)-induced RSMC proliferation. Kinetics lasting up to seven days revealed that D2A-Ala peptide completely blocked EGF-promoted RSMC proliferation. Moreover, D2A-Ala peptide inhibited invasion of HT 1080 cells towards RSMC.

Keywords: Cell invasion; Cell proliferation; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; Peptide; RSMC, rat smooth muscle cells; Urokinase receptor; uPAR, urokinase receptor.